ASTER 70s: Benefit of adjuvant chemotherapy for oestrogen receptor-positive HER2-negative breast carcinoma in women over 70 according to Genomic Grade. A French UNICANCER Geriatric Oncology Group (GERICO) and Breast Group (UCBG) multicentre phase III trial.

Category Primary study
JournalCANCER RESEARCH
Year 2012
This article has no abstract
Epistemonikos ID: f84c4a4fe7064bf09eab62cbfa3858d46611182d
First added on: Feb 05, 2025